Weak sentiment may leave Auntea Jenny thirsty for better valuation
The bubble tea chain has relaunched its Hong Kong IPO, after the Chinese securities regulator resumed approving such new listings Key Takeaways: Auntea Jenny has revived its Hong Kong listing…
Mixue pours up strong growth in China’s overheated bubble tea market
The country’s leading premium tea chain has relaunched its Hong Kong IPO, reporting 42% profit growth in the first nine months of last year even as many of its rivals…
A tea party resumes and the allure of Nvidia
Bubble tea listings on the Hong Kong Stock Exchange have resumed and a small Chinese maker of fasteners surges after a new tie-up with Nvidia. By Doug Young & Rene…
Guming IPO returns to front burner with new listing application
The maker of mid-priced fresh fruit teas could raise $300 million in its year-end Hong Kong listing, as China ends a ban on new IPOs by the group Key Takeaways:…
IPO tea party set to resume with Guming’s regulatory nod from China?
The bubble tea chain’s stalled Hong Kong listing plan could resume following its official registration by the China Securities Regulatory Commission Key Takeaways: The China Securities Regulatory Commission has officially…
PODCAST: A Bubble Tea IPO Freeze, and a Revenue-less Drug Maker
China's securities regulator puts the brakes on new bubble tea IPOs in Hong Kong. Is this China's latest step to assert its authority over the former British colony? And former drug making highflyer Ascletis has become revenue-less after its earlier drugs fizzled. Now the company is hoping to revive its fortunes with a new weight-loss drug from the same class as Ozempic.
Chinese securities regulator puts lid on Hong Kong IPO tea party
The CSRC has temporarily stopped approving new Hong Kong listings by bubble tea makers, affecting pending applications by Mixue and Guming, according to a Reuters report Key Takeaways: China’s securities…